Deciphera, a member of ONO, is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines.
Enabled by our proprietary drug discovery platform, Deciphera has developed a diverse pipeline of wholly-owned drug candidates. QINLOCK® (ripretinib) is Deciphera’s switch control inhibitor developed for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Switzerland, Taiwan, the United States, and the United Kingdom. We wholly own QINLOCK and all of our drug candidates with the exception of a development and commercialization out-license agreement for QINLOCK in Greater China. In addition to QINLOCK, we have identified and advanced multiple product candidates from our platform into clinical studies, including vimseltinib and DCC-3116.
See here for more details on our portfolio.
The role of Associate Director Market Access – International is to develop and lead execution of Market Access Strategies for the defined scope of countries, in line with International Market Access Strategy for all current and future products that Deciphera plans to place in the market. As such, the main goal of this role is to secure and maintain patient access to existing and future Deciphera products in Europe focusing on France and Italy and potentially additional regional or international responsibilities.
The Associate Director Market Access International reports to the Head of Market Access International and works closely with Global, Regional and Local cross functional stakeholders (e.g.., medical, commercial, regulatory) to ensure successful implementation of the pricing & reimbursement processes in the individual countries as well as successful implementation of international market access strategy.
Key Responsibilities:
What You’ll Bring:
What Deciphera will Bring:
Deciphera offers a comprehensive benefits package that includes but is not limited to the following:
We offer an outstanding culture and opportunity for personal and professional growth guided by our “PATHS” Core Values and how we work together. We are proud to be Great Place to Work Certified 2023 and rank #25 on Fortune’s Best Places to Work Small and Midsized Biotech Companies in 2023. Find more details about our award-winning culture here.
Clicksign
Restaurant365
Reedsy
Método Engenharia
Simprints